Replies to post #17704 on ProText Mobility Inc (TXTM)

[stervc]

Key TXTM & PLPL Connecting Variables

Below from the TXTM Investor’s page, the company has very clearly laid out the TXTM & PLPL Connecting Variables:

http://www.protextm.co/investors


v/r
Sterling

[kommisar7]

Ok here I have to answer all ...
Is the OS at PLPL still current ...?
Outstanding Shares 186,531,236 a / o Aug 15, 2016
Market Value1 $ 8,766,968 a / o Jan 20, 2017

This should bring TXTM loose 0.005 share price ...
or am I wrong...






$TXTM now presents itself as a legal MM company

Plandaí Biotechnology South Africa (Pty) Ltd, recently acquired by Protext Mobility, Inc.(OTCPINK: TXTM) is a South Africa-based research company focusing on the development of pharmaceutical applications for botanical drugs.

We are majority-owned by parent company, Plandaí Biotechnology, Inc.(OTCQB: PLPL). While headquartered in London, Plandaí operates a 100,000 square foot manufacturing facility in Mpumalanga, South Africa, where it produces Phytofare® Catechin Complex

Phytofare® is a highly bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. What this means is that Phytofare® can deliver a therapeutic level of catechins to the system where they remain active for over 24 hours.

We are initially focusing on our upcoming human clinical trial on diabetes which will help determine if Phytofare® can be effective in regulating blood sugar levels. Future research will test other potential pharmaceutical applications of catechins including anti-viral, anti-malarial, arthritis and cancer prevention. In addition, we will be working with our parent company, Plandaí, on clinical trials involving the Phytofare® Limonoid Complex for anti-inflammatory, capillary integrity, and soft tissue injury applications

[esi23]

This will be a huge RM